1 00:00:02,520 --> 00:00:07,360 Speaker 1: Bloomberg Audio Studios podcasts, radio news. 2 00:00:08,640 --> 00:00:13,040 Speaker 2: The Stock Movers podcast, your roundup of companies making moves 3 00:00:13,080 --> 00:00:16,480 Speaker 2: in the stock market, harnessing the power of Bloomberg Data. 4 00:00:17,920 --> 00:00:19,760 Speaker 1: Let's get a check on some stocks that are on 5 00:00:19,800 --> 00:00:22,320 Speaker 1: the move today with us as Bloomberg News Cross Asset 6 00:00:22,360 --> 00:00:25,760 Speaker 1: reporter Isabelle Lee. Isabelle, what are you watch him? 7 00:00:25,840 --> 00:00:29,440 Speaker 3: American Towers, so shares are edging higher by almost five percent, 8 00:00:29,480 --> 00:00:32,600 Speaker 3: and that's after the company reported earnings that beat expectations 9 00:00:32,840 --> 00:00:34,800 Speaker 3: and give an outlook that is seen as positive. So 10 00:00:34,840 --> 00:00:39,760 Speaker 3: American Tower is a wireless communications real estate investment trust, 11 00:00:40,479 --> 00:00:42,519 Speaker 3: So that took me a while to really understand. So 12 00:00:42,560 --> 00:00:45,360 Speaker 3: for the first quarter that adjusted EBITA was hired in estimates, 13 00:00:45,360 --> 00:00:47,360 Speaker 3: as was the revenue, and for the year ahead it 14 00:00:47,400 --> 00:00:49,720 Speaker 3: was the same story. We have Key Bank Capital Markets 15 00:00:49,720 --> 00:00:52,640 Speaker 3: seeing the results are positive and the better than expected 16 00:00:52,680 --> 00:00:55,360 Speaker 3: on key Metrics results was great. We have Cities saying 17 00:00:55,360 --> 00:00:57,400 Speaker 3: the same thing, the results are positive, and we have 18 00:00:57,440 --> 00:00:59,960 Speaker 3: more at Nathanson saying that these are strong results and 19 00:01:00,520 --> 00:01:02,720 Speaker 3: they said that this boats well for the growth over 20 00:01:02,760 --> 00:01:05,960 Speaker 3: the coming periods. You're also looking at shares of Honeywell 21 00:01:06,040 --> 00:01:08,960 Speaker 3: Right gaining almost five percent today, yes, lots of green 22 00:01:09,000 --> 00:01:11,280 Speaker 3: on the screen, so honeywell, that's an industrial conglomerate. They 23 00:01:11,400 --> 00:01:14,640 Speaker 3: raise their folio guidance for their EPs. So the company, 24 00:01:14,640 --> 00:01:18,399 Speaker 3: which plants to split the company into three separate companies, 25 00:01:18,720 --> 00:01:20,840 Speaker 3: also said that they will use a multi prong approach 26 00:01:20,880 --> 00:01:24,000 Speaker 3: to offset around five hundred million dollars in TIREFF exposure. 27 00:01:24,040 --> 00:01:27,560 Speaker 3: So this includes targeting, pricing moves and finding alternative sources 28 00:01:27,560 --> 00:01:30,600 Speaker 3: for supplies. And still the outlook for the demand remains uncertain. 29 00:01:30,640 --> 00:01:33,000 Speaker 3: We have JP Morgan giving a nuanced comment. They said 30 00:01:33,000 --> 00:01:35,440 Speaker 3: that quote, it's a solid quarter, though not quite as 31 00:01:35,440 --> 00:01:38,120 Speaker 3: strong as the headline suggests, with most of the upside 32 00:01:38,120 --> 00:01:40,119 Speaker 3: from the below the line items for the first quarter. 33 00:01:40,400 --> 00:01:42,560 Speaker 3: They also gave a nod. They said that raising the eps' 34 00:01:42,600 --> 00:01:44,800 Speaker 3: outlook and offsetting the five hundred million dollars of tire 35 00:01:44,880 --> 00:01:48,640 Speaker 3: for exposure reflects agile operational execution. 36 00:01:49,080 --> 00:01:51,600 Speaker 1: All right, you're also watching shares of Pfizer in the 37 00:01:51,600 --> 00:01:53,080 Speaker 1: pharmer space. What's going on with Pfizer? 38 00:01:53,320 --> 00:01:55,800 Speaker 3: This is also edging higher by nearly four percent, So 39 00:01:55,840 --> 00:01:58,160 Speaker 3: the company is cutting another one point two billion dollars 40 00:01:58,360 --> 00:02:00,960 Speaker 3: from its spending while they really search for the next 41 00:02:00,960 --> 00:02:03,240 Speaker 3: big hit. We know that their ob City pill failed. 42 00:02:03,400 --> 00:02:06,200 Speaker 3: In an interview with Bloomberg, the CEO said it expects 43 00:02:06,240 --> 00:02:09,280 Speaker 3: to pull off three or two or three deals totally 44 00:02:09,280 --> 00:02:11,600 Speaker 3: as much as fifteen billion dollars this year, really just 45 00:02:11,639 --> 00:02:14,919 Speaker 3: to replenish the pipeline after again the failed ob City pill. 46 00:02:15,000 --> 00:02:18,040 Speaker 3: So the company's first quader revenue also fell short estimates, 47 00:02:18,360 --> 00:02:20,600 Speaker 3: but they did maintain their twenty twenty five outlooks. So 48 00:02:20,880 --> 00:02:23,520 Speaker 3: we talked about this early, and it's interesting that investors 49 00:02:23,560 --> 00:02:25,800 Speaker 3: are choosing to focus on the positive, because sometimes they 50 00:02:25,880 --> 00:02:28,400 Speaker 3: choose to focus on the negative. The company didn't give 51 00:02:28,440 --> 00:02:30,840 Speaker 3: details though on how existing TIFFs will impact their business, 52 00:02:30,880 --> 00:02:33,200 Speaker 3: so that's another ambiguity right there. 53 00:02:33,360 --> 00:02:35,720 Speaker 1: YEA, for four straight days, Well, it's pretty remarkable. I mean, 54 00:02:35,760 --> 00:02:37,320 Speaker 1: I'm zooming out on the chart right now. I'm looking 55 00:02:37,360 --> 00:02:40,239 Speaker 1: at its high back on December of twenty twenty one. 56 00:02:40,440 --> 00:02:43,040 Speaker 1: This is remember at the height of the COVID pandemic, 57 00:02:43,120 --> 00:02:44,600 Speaker 1: when it was one of the two well, I don't 58 00:02:44,600 --> 00:02:45,800 Speaker 1: want to say one of the two, but one of 59 00:02:45,880 --> 00:02:48,000 Speaker 1: several shots that were approved, one of the two mRNA 60 00:02:48,080 --> 00:02:51,760 Speaker 1: vaccines that were approved here in the US. Down fifty 61 00:02:51,800 --> 00:02:53,520 Speaker 1: four percent, absolutely, so. 62 00:02:53,440 --> 00:02:56,520 Speaker 3: They've really struggled amid the declining demand for COVID vaccines, Like, 63 00:02:56,560 --> 00:02:59,639 Speaker 3: I mean, who was even maybe some people are actually 64 00:02:59,639 --> 00:03:02,639 Speaker 3: still to making those shots. But what's the next big 65 00:03:02,680 --> 00:03:04,200 Speaker 3: thing for them? I mean, it can't be a one 66 00:03:04,280 --> 00:03:06,519 Speaker 3: hit wonder, and they have a sivers of multi billion 67 00:03:06,560 --> 00:03:09,000 Speaker 3: dollar acquisitions and that still really hasn't panned out. 68 00:03:09,360 --> 00:03:11,680 Speaker 1: Yeah, and the weight loss hiccup too that they had, 69 00:03:11,760 --> 00:03:14,520 Speaker 1: especially competing with a company such as Novo Nordisk and 70 00:03:14,600 --> 00:03:15,320 Speaker 1: Eli Lilly. 71 00:03:15,760 --> 00:03:17,720 Speaker 3: Yes, so we'll see what happens to them, but for 72 00:03:17,800 --> 00:03:22,280 Speaker 3: now it's looking like they might have something after that 73 00:03:22,280 --> 00:03:24,959 Speaker 3: failed a visit to pill But for you're right, five 74 00:03:25,040 --> 00:03:27,919 Speaker 3: years with that time horizon, they're down thirty percent. 75 00:03:29,880 --> 00:03:34,000 Speaker 2: The Stock Movers podcast from Bloomberg Radio. Check back with 76 00:03:34,080 --> 00:03:36,840 Speaker 2: us throughout the day for the latest roundup of companies 77 00:03:36,880 --> 00:03:39,920 Speaker 2: making news on Wall Street and for the latest market 78 00:03:39,960 --> 00:03:44,320 Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, 79 00:03:44,360 --> 00:03:47,640 Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with 80 00:03:47,680 --> 00:03:49,160 Speaker 2: the Bloomberg Business app.